Literature DB >> 20504873

Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries.

Weon-Young Son1, Seang Lin Tan.   

Abstract

BACKGROUND: In this review, recent advances in the laboratory as well as embryological aspects of hCG priming in vitro maturation (IVM) cycles are described.
METHODS: This report is based on publications from literature searches and the authors' experience.
RESULTS: In IVM cycles, priming with hCG permits the recovery of a certain number of oocytes with an expanding/dispersed cumulus pattern which facilitates its identification within follicular fluid as compared with non-primed IVM cycles. The immature oocytes with dispersed cumulus cells (CC) at collection have high IVM rates and embryo development potentials. Moreover, a few in vivo matured oocytes with dispersed CC can be obtained, and these have produced good quality embryos. hCG can be given to patients when a dominant follicle reaches 10-12 mm to avoid negative effects on the sibling immature oocytes. ICSI should be performed at least 1 h after the first polar body extrusion. Embryo transfer time depends on quantity and quality of the embryos produced after IVM. Compared with slow freezing, vitrification is a more efficient method for freezing the embryos produced from IVM.
CONCLUSIONS: The data from the meta-analyses suggests that the effect on clinical outcome of gonadotrophin priming of IVM still needs to be studied. In order to improve the IVM programs, it is essential to define not only the clinical aspects but also the laboratory and embryological aspects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20504873     DOI: 10.1093/humupd/dmq014

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  37 in total

1.  In-vitro maturation of human oocytes: before or after vitrification?

Authors:  Giovanna Fasano; Isabelle Demeestere; Yvon Englert
Journal:  J Assist Reprod Genet       Date:  2012-04-04       Impact factor: 3.412

2.  Successful pregnancy following a novel endometrial preparation in a PCOS patient undergoing IVM: a case report.

Authors:  Maryam Eftekhar; Mohammad Ali Khalili; Abbas Aflatoonian; Navid Esfandiari
Journal:  J Assist Reprod Genet       Date:  2012-02-18       Impact factor: 3.412

3.  Comparison of fertilization and embryonic development in sibling in vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles.

Authors:  Weon-Young Son; Jin-Tae Chung; Michael Dahan; Shauna Reinblatt; Seang Lin Tan; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2010-12-29       Impact factor: 3.412

4.  Morphokinetics of embryos developed from oocytes matured in vitro.

Authors:  Mariabeatrice Dal Canto; Paola V Novara; Giovanni Coticchio; Mario Mignini Renzini; Fausta Brambillasca; Claudio Brigante; Elena De Ponti; Rubens Fadini
Journal:  J Assist Reprod Genet       Date:  2015-12-04       Impact factor: 3.412

5.  A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy.

Authors:  B I Rose
Journal:  J Assist Reprod Genet       Date:  2013-12-01       Impact factor: 3.412

6.  Targeted disruption of Nrg1 in granulosa cells alters the temporal progression of oocyte maturation.

Authors:  Ikko Kawashima; Takashi Umehara; Noritaka Noma; Tomoko Kawai; Manami Shitanaka; Joanne S Richards; Masayuki Shimada
Journal:  Mol Endocrinol       Date:  2014-03-20

Review 7.  Controversies in IVM.

Authors:  Shauna Leigh Reinblatt; Weon-Young Son; Einat Shalom-Paz; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2011-05-10       Impact factor: 3.412

8.  Mosaic embryo transfer after oocyte in vitro maturation in combination with non-invasive prenatal testing (NIPT)-first report of a euploid live birth.

Authors:  Naomi Inoue; Rosmary Lopez; Andrea Delgado; Denisse Nuñez; Jimmy Portella; Luis Noriega-Hoces; Luis Guzmán
Journal:  J Assist Reprod Genet       Date:  2017-06-24       Impact factor: 3.412

9.  Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.

Authors:  Helene Creux; Patricia Monnier; Weon-Young Son; William Buckett
Journal:  J Assist Reprod Genet       Date:  2018-03-03       Impact factor: 3.412

10.  Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue.

Authors:  Dmitry Nikiforov; Cheng Junping; Jesus Cadenas; Vallari Shukla; Robert Blanshard; Susanne Elisabeth Pors; Stine Gry Kristensen; Kirsten Tryde Macklon; Lotte Colmorn; Erik Ernst; Anne-Mette Bay-Bjørn; Zeinab Ghezelayagh; Yu Wakimoto; Marie Louise Grøndahl; Eva Hoffmann; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.